Showing 1 - 20 results of 27 for search 'Daniela Cilloni', query time: 0.05s Refine Results
  1. 1
    Iron Chelation Therapy in Myelodysplastic Syndromes

    Iron Chelation Therapy in Myelodysplastic Syndromes by Emanuela Messa, Daniela Cilloni, Giuseppe Saglio

    Published 2010-01-01
    Get full text
    Article
  2. 2
    Nuclear factor κB as a target for new drug development in myeloid malignancies

    Nuclear factor κB as a target for new drug development in myeloid malignancies by Daniela Cilloni, Giovanni Martinelli, Francesca Messa, Michele Baccarani, Giuseppe Saglio

    Published 2007-09-01
    Get full text
    Article
  3. 3
    Long-term molecular responses to imatinib in patients with chronic myeloid leukemia: comparison between complete cytogenetic responders treated in early and in late chronic phase

    Long-term molecular responses to imatinib in patients with chronic myeloid leukemia: comparison between complete cytogenetic responders treated in early and in late chronic phase by Francesca Palandri, Ilaria Iacobucci, Fabrizio Quarantelli, Fausto Castagnetti, Daniela Cilloni, Michele Baccarani

    Published 2007-11-01
    Get full text
    Article
  4. 4
    Aurora kinase inhibitors: which role in the treatment of chronic myelogenous leukemia patients resistant to imatinib?

    Aurora kinase inhibitors: which role in the treatment of chronic myelogenous leukemia patients resistant to imatinib? by Giovanni Martinelli, Simona Soverini, Ilaria Iacobucci, Cristina Papayannidis, Daniela Cilloni, Michele Baccarani

    Published 2009-02-01
    Get full text
    Article
  5. 5
    Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients

    Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients by Antonio Bertolotto, Serena Martire, Luca Mirabile, Marco Capobianco, Marco De Gobbi, Daniela Cilloni

    Published 2020-06-01
    Get full text
    Article
  6. 6
    PB2177: MULTICENTRE RETROSPECTIVE OBSERVATIONAL STUDY ON PATIENTS WITH MYELOFIBROSIS IN PIEDMONT. ROLE OF INFLAMMATION AND DYSIMMUNITY. MFACTORS STUDY.

    PB2177: MULTICENTRE RETROSPECTIVE OBSERVATIONAL STUDY ON PATIENTS WITH MYELOFIBROSIS IN PIEDMONT. ROLE OF INFLAMMATION AND DYSIMMUNITY. MFACTORS STUDY. by Valentina Bonuomo, Marco Armenio, Daniela Cilloni, Federico Itri, Monia Marchetti, Selene Grano, Carmen Fava

    Published 2023-08-01
    Get full text
    Article
  7. 7
    Ruxolitinib and pegylated interferon in Chronic Neutrophilic Leukemia due to a pathogenic CSF3R germline variant: a case report

    Ruxolitinib and pegylated interferon in Chronic Neutrophilic Leukemia due to a pathogenic CSF3R germline variant: a case report by Selene Grano, Valentina Bonuomo, Diana Carli, Veronica Peri, Loredana Farinasso, Ugo Ramenghi, Daniela Cilloni, Carmen Fava

    Published 2024-12-01
    Get full text
    Article
  8. 8
    Clonal hematopoiesis by DNMT3A mutations as a common finding in idiopathic splanchnic vein thrombosis

    Clonal hematopoiesis by DNMT3A mutations as a common finding in idiopathic splanchnic vein thrombosis by Giovanna Carrà, Emilia Giugliano, Sofia Camerlo, Giorgio Rosati, Enrica Branca, Beatrice Maffeo, Isabella Russo, Rocco Piazza, Daniela Cilloni, Alessandro Morotti

    Published 2022-10-01
    Get full text
    Article
  9. 9
    A new BCR-ABL1 Drosophila model as a powerful tool to elucidate the pathogenesis and progression of chronic myeloid leukemia

    A new BCR-ABL1 Drosophila model as a powerful tool to elucidate the pathogenesis and progression of chronic myeloid leukemia by Roberto Bernardoni, Giorgia Giordani, Elisabetta Signorino, Sara Monticelli, Francesca Messa, Monica Pradotto, Valentina Rosso, Enrico Bracco, Angela Giangrande, Giovanni Perini, Giuseppe Saglio, Daniela Cilloni

    Published 2019-04-01
    Get full text
    Article
  10. 10
    Rhino-Orbital-Cerebral Mucormycosis after Allogeneic Hematopoietic Stem Cell Transplantation and Isavuconazole Therapeutic Drug Monitoring during Intestinal Graft versus Host Disease

    Rhino-Orbital-Cerebral Mucormycosis after Allogeneic Hematopoietic Stem Cell Transplantation and Isavuconazole Therapeutic Drug Monitoring during Intestinal Graft versus Host Disea... by Giacomo Andreani, Gianluca Fadda, Dario Gned, Matteo Dragani, Giovanni Cavallo, Valentina Monticone, Alessandro Morotti, Marco De Gobbi, Angelo Guerrasio, Antonio D'Avolio, Daniela Cilloni

    Published 2019-10-01
    Get full text
    Article
  11. 11
    P1024: MYLOX-1: A PHASE II STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL LOXL2 INHIBITOR GB2064 (WITH FOCUS ON BONE MARROW COLLAGEN) IN PATIENTS WITH MYELOFIBROSIS

    P1024: MYLOX-1: A PHASE II STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL LOXL2 INHIBITOR GB2064 (WITH FOCUS ON BONE MARROW COLLAGEN) IN P... by Claire Harrison, John Mascarenhas, Daniela Cilloni, Richard Schlenk, Brian Jacoby, Robert J Slack, Vassilios Aslanis, Bhupinder Singh, Bertil Lindmark, Srdan Verstovsek, Raajit K Rampal

    Published 2023-08-01
    Get full text
    Article
  12. 12
    HSCT with Mismatched Unrelated Donors (MMUD): A Comparison of Different Platforms for GvHD Prophylaxis

    HSCT with Mismatched Unrelated Donors (MMUD): A Comparison of Different Platforms for GvHD Prophylaxis by Massimo Berger, Marta Barone, Fabrizio Carnevale-Schianca, Marco De Gobbi, Paolo Nicoli, Daniela Caravelli, Daniela Cilloni, Luca Paruzzo, Manuela Spadea, Katia Mareschi, Massimo Aglietta, Franca Fagioli

    Published 2022-02-01
    Get full text
    Article
  13. 13
    Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy

    Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy by Daniela Cilloni, Francesca Messa, Francesca Arruga, Ilaria Defilippi, Enrico Gottardi, Milena Fava, Sonia Carturan, Renata Catalano, Enrico Bracco, Emanuela Messa, Paolo Nicoli, Daniela Diverio, Miguel A. Sanz, Giovanni Martinelli, Francesco Lo-Coco, Giuseppe Saglio

    Published 2008-06-01
    Get full text
    Article
  14. 14
    PB2672: EXPLORING UNMET NEEDS OF PATIENTS WITH MYELODYSPLASTIC NEOPLASMS AND CAREGIVERS IN A NATIONAL ITALIAN SURVEY

    PB2672: EXPLORING UNMET NEEDS OF PATIENTS WITH MYELODYSPLASTIC NEOPLASMS AND CAREGIVERS IN A NATIONAL ITALIAN SURVEY by Elena Crisà, Annamaria Nosari, Daniela Cilloni, Sam Salek, Tatyana Ionova, Matteo Giovanni Della Porta, Maria Teresa Voso, Luca Maurillo, Carlo Finelli, Valeria Santini, Enrico Balleari, Federica Pilo, Giuseppe Palumbo, Alfredo Molteni, Marta Riva, Esther Oliva

    Published 2023-08-01
    Get full text
    Article
  15. 15
    Deferasirox is a powerful NF-κB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging

    Deferasirox is a powerful NF-κB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen speci... by Emanuela Messa, Sonia Carturan, Chiara Maffè, Marisa Pautasso, Enrico Bracco, Antonella Roetto, Francesca Messa, Francesca Arruga, Ilaria Defilippi, Valentina Rosso, Chiara Zanone, Antonia Rotolo, Elisabetta Greco, Rosa M. Pellegrino, Daniele Alberti, Giuseppe Saglio, Daniela Cilloni

    Published 2010-08-01
    Get full text
    Article
  16. 16
    Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party

    Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party by Gianantonio Rosti, Ilaria Iacobucci, Simona Bassi, Fausto Castagnetti, Marilina Amabile, Daniela Cilloni, Angela Poerio, Simona Soverini, Francesca Palandri, Giovanna Rege Cambrin, Franco Iuliano, Giuliana Alimena, Roberto Latagliata, Nicoletta Testoni, Fabrizio Pane, Giuseppe Saglio, Michele Baccarani, Giovanni Martinelli

    Published 2007-01-01
    Get full text
    Article
  17. 17
    Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain

    Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain by Simona Soverini, Sabrina Colarossi, Alessandra Gnani, Fausto Castagnetti, Gianantonio Rosti, Costanza Bosi, Stefania Paolini, Michela Rondoni, Pier Paolo Piccaluga, Francesca Palandri, Panagiota Giannoulia, Giulia Marzocchi, Simona Luatti, Nicoletta Testoni, Ilaria Iacobucci, Daniela Cilloni, Giuseppe Saglio, Michele Baccarani, Giovanni Martinelli

    Published 2007-03-01
    Get full text
    Article
  18. 18
    Chronic phase chronic myeloid leukemia patients with low OCT-1 activity randomized to high-dose imatinib achieve better responses and have lower failure rates than those randomized to standard-dose imatinib

    Chronic phase chronic myeloid leukemia patients with low OCT-1 activity randomized to high-dose imatinib achieve better responses and have lower failure rates than those randomized... by Deborah L. White, Jerald Radich, Simona Soverini, Verity A Saunders, Amity K. Frede, Phuong Dang, Daniela Cilloni, Peter Lin, Lidia Mongay, Richard Woodman, Paul Manley, Cassandra Slader, Dong Wook Kim, Fabrizio Pane, Giovanni Martinelli, Giuseppe Saglio, Timothy P. Hughes

    Published 2012-06-01
    Get full text
    Article
  19. 19
    The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party

    The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working... by Ilaria Iacobucci, Annalisa Lonetti, Francesca Paoloni, Cristina Papayannidis, Anna Ferrari, Clelia Tiziana Storlazzi, Marco Vignetti, Daniela Cilloni, Francesca Messa, Viviana Guadagnuolo, Stefania Paolini, Loredana Elia, Monica Messina, Antonella Vitale, Giovanna Meloni, Simona Soverini, Fabrizio Pane, Michele Baccarani, Robin Foà, Giovanni Martinelli

    Published 2010-10-01
    Get full text
    Article
  20. 20
    The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRα-positive hypereosinophilic syndrome. Results of a multicenter prospective study

    The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRα-positive hypereosinophilic syndrome. Results of a multicenter prospective study by Michele Baccarani, Daniela Cilloni, Michela Rondoni, Emanuela Ottaviani, Francesca Messa, Serena Merante, Mario Tiribelli, Francesco Buccisano, Nicoletta Testoni, Enrico Gottardi, Antonio de Vivo, Emilia Giugliano, Ilaria Iacobucci, Stefania Paolini, Simona Soverini, Gianantonio Rosti, Francesca Rancati, Cinzia Astolfi, Fabrizio Pane, Giuseppe Saglio, Giovanni Martinelli

    Published 2007-09-01
    Get full text
    Article

Search Tools: